Abiopharma

UK COMPETITION AND MARKETS AUTHORITY APPROVES PARAMOUNT SKYDANCE CORPORATION ACQUISITION OF WARNER BROS. DISCOVERY

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Sunrise Realty Trust, Inc. Announces Financial Results for the Second Quarter 2026

Change - Announcement of Appointment: Appointment of Huang Yinghong as Independent Director

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

BioVie Inc. - BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

Nuvation Bio Inc. - Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Agenus Inc. - Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer

General Announcement: Appointment and Re-designation of Independent Directors and Changes to Composition of the Board

Form 6-K Nova Reports Record Second Quarter 2026 Financial Results

ZenaTech Closes 27th Drone as a Service Acquisition Expanding into Idaho, Strengthening Drone-Based Surveying and Civil Engineering Services for Government and Construction Customers

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

HPQ ENDURA+ GEN4 21700 Cells Achieve UN 38.3 Certification Supports Ongoing Customer Qualification Activities